Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis - Top-Institutions - MDSpire

Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis

  • By

  • Olayinka Abraham Ojedele

  • Norah Hamdi

  • Mohammed H. AL Mughram

  • Esmael M. Alyami

  • Mohammed Dauelbait

  • Omar A. Almohammed

  • November 25, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Pharmacology
    • Molecular Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Drug Discovery
    • Computational Biology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer Treatment
    • Pharmacology
    • Molecular Modeling

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cancer Pharmacology
    • Molecular Oncology
    • Computational Drug Design

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Breast Cancer Research
    • Pharmacology
    • Computational Biology

Original Source(s)

Exploration of New Aromatase Inhibitors as Treatment Options for Breast Cancer: A Study on Molecular Docking, Molecular Dynamics Simulations, and ADMET Analysis

  • by Olayinka Abraham Ojedele, Norah Hamdi, Mohammed H. AL Mughram, Esmael M. Alyami, Mohammed Dauelbait, Omar A. Almohammed

  • November 25, 2025

Related Content

Mesh-free prepectoral breast reconstruction: a safe and effective alternative

Diagnostic value of multimodal ultrasound imaging in triple-negative breast cancer

Successful reversal of hepatic visceral crisis in HER2-positive metastatic breast cancer: a case report